Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Covance Opens New Clinical CRO Facility in Shanghai

publication date: Sep 18, 2019

Covance, a global drug CRO, opened a new 12,000 square meter R&D center focused on clinical services in Shanghai's Zhangjiang Hi-Tech Park. The company claims the new center is the largest CRO facility in the Asia Pacific region. It offers clinical development and commercialization services, plus bioanalytical and central laboratory services. The new center is near Covance's other Shanghai facility, which focuses on Early Development services including safety assessment, metabolism and lead optimization. The company did not disclose the cost of its new R&D center. More details....

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China